Chulabhorn Research Institute

Lak Si 10210

0 studies enrolling now · 1 studies all time

What they study most

NSCLC, Non-small Cell Lung Cancer

Studies at this site

• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early